About Us

Molecular Health in less than a minute...

Molecular Health was founded in 2004, and since then it has stood for transforming big data into precise, actionable decisions for all stakeholders in healthcare.

Our cloud-based Dataome technology platform analyzes the molecular and clinical data of individual patients against the world's medical, biological, and pharmacological knowledge, to drive more precise diagnostic, therapeutic, and drug safety decisions.

Our range of products is used across the healthcare sector, as more precise ways of practicing medicine impact the treatment of patients and the development of effective drugs, requiring ever more complex levels of data interpretation.

The company is financed by Dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.

 

Our Mission

Our mission is to transform big data in medicine into precise, actionable decisions for all stakeholders in healthcare.

Board of Directors

Prof. Christof Hettich, PhD

Christof Hettich is a lawyer and partner at RITTERSHAUS Rechtsanwälte in Mannheim/Frankfurt/Munich and is also the co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG.

Mathias Hothum, PhD

Mathias Hothum, owner of HMM-Consulting, received a degree in Economics from the University of Mannheim. He completed his doctoral studies at the University of Magdeburg.

Alexander Schuth, MD

Alexander Schuth is co-founder and COO of Denali Therapeutics, a San Francisco based biotech company dedicated to the discovery and development of therapies for neurodegenerative diseases. He holds an M.B.A. from the Wharton School and an M.D. from the Charite Medical School at the Humboldt University.

Management Team

Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer
Gerry Sheridan
Chief Financial Officer
Stephan Brock, PhD
Chief Technology Officer
Les Paul, MD, MSc
Chief Medical Officer
Rudolf Caspary, PhD
Chief Information Officer
David Jackson, PhD
Chief Innovation Officer
Blanca Baez
Global Head of BD – Pharma & Biotech
Stephan Hettich, Dipl.-Kfm.
SVP, Head of Business Development, Sales and Marketing EMEA
Tom Strilko
SVP Sales & Business Development USA
Niels Bojunga, PhD
SVP Quality Management
Thorsten Vogt
Head of HR
Michael Ghaffar, LL.M.
General Counsel
Torsten Bürgermeister
SVP Finance & Administration

Our Partners

Molecular Health's growing number of customers and partnerships include some of the best laboratories, universities, and genetic facilities in the world.

MD Anderson Cancer Center, Houston
MD Anderson Cancer Center, Houston, Texas
US Department of Health and Human  Services Food and Drug Administration
FDA - US Department of Health and Human Services Food and Drug Administration
SAP
SAP
German Cancer Research Center
dkfz - German Cancer Research Center
NCT
NCT - National Center For Tumor Diseases, Heidelberg
Karolinska Institutet
Karolinska Institutet, Stockholm, Sweden
UniversitätsKlinikum Heidelberg
UniversitätsKlinikum Heidelberg
Hochtaunus Kliniken
HTK - Hochtaunus Kliniken
University of Florida College of Pharmacy
University of Florida College of Pharmacy
Guardian Research Network
Guardian Research Network
Gibbs Cancer Center & Research Institute Hochtaunus Kliniken
Gibbs Cancer Center & Research Institute

Certifications

CLIA & ISO/IEC 15189 Accreditation

The US laboratory, based in Houston, Texas, is CLIA and ISO 15189 accredited by the American Association for Laboratory Accreditation (A2LA).

Molecular Health CAP Accreditation Certificate

The MH laboratory is accredited by the College of American Pathologists.

Molecular Health CLIA Certificate

Centers for Medicare & Medicaid Services Clinical Laboratory Improvement Amendments (CLIA) certificate of accreditation.

Rhode Island State License

Molecular Health is authorized to accept clinical samples from the State of Rhode Island for clinical laboratory services in our laboratory in Texas, US.

Florida State License

Molecular Health is authorized to accept clinical samples from the State of Florida for clinical laboratory services in our laboratory in Texas, US.

Pennsylvania State License

Molecular Health is authorized to accept clinical samples from the State of Pennsylvania for clinical laboratory services in our laboratory in Texas, US.

Maryland State License

Molecular Health is authorized to accept clinical samples from the State of Maryland for clinical laboratory services in our laboratory in Texas, US.

California State License

Molecular Health is authorized to accept clinical specimens from the State of California for clinical laboratory services in our laboratory in Texas, US.

ISO 13485

Audited and certified per ISO 13485 for the design, development, and production of software systems for the integrated analysis of clinical and genomic patient data to support treatment decisions and provision of related services.

Investors

Molecular Health was founded in 2004, and since then it has stood for transforming big data into precise, actionable decisions for all stakeholders in healthcare.

The company is financed by Dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.

Dievini

Dievini is an active investor in life and health sciences companies. The company is dedicated to advancing innovative therapeutic and diagnostic technologies to establish novel treatment regimens for life-threatening diseases. Established by Dietmar Hopp, founder and former Chairman and CEO of SAP, the company maintains deep roots in the health and technology sectors and is led by a team with an extensive track record of building scalable, sustainable life science and health technology companies.

advisors in health sciences